Davor Pavlin-Premrl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Davor Pavlin-Premrl has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Hamed Asadi
Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
3 shared publicationsJulian Maingard
Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
3 shared publicationsRamon Martin Francisco Bañez
Department of Interventional Neuroradiology, Royal Hobart Hospital, Hobart, Tasmania, Australia
3 shared publicationsVincent Thijs
Department of Neurology, Austin Hospital, Heidelberg, Australia; Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
3 shared publicationsAdrian Praeger
Department of Neurosurgery, Monash Health, Clayton, Victoria, Australia
2 shared publications- Albert Ho Yuen Chiu
Neurological Intervention & Imaging Service of Western Australia (NIISwa), Sir Charles Gairdner, Royal Perth and Fiona Stanley Hospitals, Western Australia Department of Health, Nedlands, Western Australia, Australia
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (11) , 108758
How vascular territories change in intracranial atherosclerosis - a CT perfusion flow territory mapping study
- 7 October 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (11) , 108758
Open AccessHow vascular territories change in intracranial atherosclerosis - a CT perfusion flow territory mapping study
- Open Access
Vasculopathy of the small vessels is common in lacunar stroke - a 7T MRI study
Background: Lacunar stroke is a common and disabling cerebrovascular disease. Small-vessel vasculopathy is thought to be the most common underlying cause, but this has only been identified on histopathology. 7T MRI allows small vessels to be seen in vivo. This study aimed to investigate rates of small vessel vasculopathy in lacunar stroke using 7T MRI. Methods: Patients with lacunar stroke at an Australian tertiary stroke centre were prospectively screened and recruited to the study. Patients underwent 7T MRI with T1, T2, time-of-flight (TOF), diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI) sequences. Images were interpreted by two blinded neuroradiologists. Results: The likely symptomatic perforator could be identified in 16/19 (84%) of cases. Amongst cases where the symptomatic perforator was observed, 14/16 (88%) of the symptomatic perforator vessels had focal stenosis consistent with steno-occlusive vasculopathy. There were 3/19 (16%) of cases with associated large artery vasculopathy. There were 7/16 (44%) cases where an occluded perforator was seen. The majority of patients had at least one vascular risk factor (15/19, 79%) and there were no cases where non-atherosclerotic vasculopathy was suspected. Conclusions: Lacunar stroke is commonly associated with small vessel vasculopathy, likely due to atherosclerosis, which can be identified in vivo with 7T MRI time-of-flight imaging.
Open AccessVasculopathy of the small vessels is common in lacunar stroke - a 7T MRI study
Background: Lacunar stroke is a common and disabling cerebrovascular disease. Small-vessel vasculopathy is thought to be the most common underlying cause, but this has only been identified on histopathology. 7T MRI allows small vessels to be seen in vivo. This study aimed to investigate rates of small vessel vasculopathy in lacunar stroke using 7T MRI. Methods: Patients with lacunar stroke at an Australian tertiary stroke centre were prospectively screened and recruited to the study. Patients underwent 7T MRI with T1, T2, time-of-flight (TOF), diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI) sequences. Images were interpreted by two blinded neuroradiologists. Results: The likely symptomatic perforator could be identified in 16/19 (84%) of cases. Amongst cases where the symptomatic perforator was observed, 14/16 (88%) of the symptomatic perforator vessels had focal stenosis consistent with steno-occlusive vasculopathy. There were 3/19 (16%) of cases with associated large artery vasculopathy. There were 7/16 (44%) cases where an occluded perforator was seen. The majority of patients had at least one vascular risk factor (15/19, 79%) and there were no cases where non-atherosclerotic vasculopathy was suspected. Conclusions: Lacunar stroke is commonly associated with small vessel vasculopathy, likely due to atherosclerosis, which can be identified in vivo with 7T MRI time-of-flight imaging.
- Open Access
- 1 January 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (1) , e001208
Same-territory chronic infarcts are common in intracranial atherosclerosis and are associated with future recurrence
Background: Intracranial atherosclerotic disease (ICAD) has a high risk of symptomatic recurrence. We investigated the prevalence of same-territory chronic infarcts among symptomatic ICAD patients, and their ability to discriminate between absence and presence of future same-territory ischaemic events. Methods: In a retrospective analysis of prospectively collected data from two Australian stroke centres, patients were followed for recurrent ischaemia over 12 months. Ability to discriminate between absence and presence of recurrent stroke/TIA (Area-under-curve (AUC) in receiver-operating-characteristic analysis) and degree of model fit (Bayesian information criterion (BIC)) were compared for prognostic characteristics of chronic same-territory stroke, >70% stenosis and CT-perfusion hypoperfusion. Results: From 2019 to 2020, 135 patients had symptomatic ICAD, mean age 73.8 (SD±13.2) and 57/135 (42%) female, of whom 29/135 (21%) had chronic same-territory infarcts. Over a 12-month follow-up period, recurrent cerebrovascular events occurred in 9/29 (31%) patients with, and in 11/106 (10%) without, chronic same-territory stroke (OR 3.9 95% CI 1.4 to 10.6, p=0.008). In discrimination and model fit analysis, BIC indicated strong evidence for improved model fit, for same-territory chronic infarction (AUC 0.64) vs >70% stenosis (AUC 0.58, p=0.59; BIC difference 4.7). In n=99 with CT-perfusion, chronic infarct showed better fit than CT-perfusion hypoperfusion (0.64 vs 0.61, p=0.79; BIC difference 2.8). Chronic infarct alone also outperformed all combinations of chronic infarct, hypoperfusion and >70% stenosis in model fit. Conclusions: Chronic same-territory infarcts are common among patients presenting with symptomatic ICAD and can better discriminate future same-territory ischaemic cerebrovascular events over a 12-month period than stenosis>70% and hypoperfusion on CTP.
- 1 January 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (1) , e001208
Open AccessSame-territory chronic infarcts are common in intracranial atherosclerosis and are associated with future recurrence
Background: Intracranial atherosclerotic disease (ICAD) has a high risk of symptomatic recurrence. We investigated the prevalence of same-territory chronic infarcts among symptomatic ICAD patients, and their ability to discriminate between absence and presence of future same-territory ischaemic events. Methods: In a retrospective analysis of prospectively collected data from two Australian stroke centres, patients were followed for recurrent ischaemia over 12 months. Ability to discriminate between absence and presence of recurrent stroke/TIA (Area-under-curve (AUC) in receiver-operating-characteristic analysis) and degree of model fit (Bayesian information criterion (BIC)) were compared for prognostic characteristics of chronic same-territory stroke, >70% stenosis and CT-perfusion hypoperfusion. Results: From 2019 to 2020, 135 patients had symptomatic ICAD, mean age 73.8 (SD±13.2) and 57/135 (42%) female, of whom 29/135 (21%) had chronic same-territory infarcts. Over a 12-month follow-up period, recurrent cerebrovascular events occurred in 9/29 (31%) patients with, and in 11/106 (10%) without, chronic same-territory stroke (OR 3.9 95% CI 1.4 to 10.6, p=0.008). In discrimination and model fit analysis, BIC indicated strong evidence for improved model fit, for same-territory chronic infarction (AUC 0.64) vs >70% stenosis (AUC 0.58, p=0.59; BIC difference 4.7). In n=99 with CT-perfusion, chronic infarct showed better fit than CT-perfusion hypoperfusion (0.64 vs 0.61, p=0.79; BIC difference 2.8). Chronic infarct alone also outperformed all combinations of chronic infarct, hypoperfusion and >70% stenosis in model fit. Conclusions: Chronic same-territory infarcts are common among patients presenting with symptomatic ICAD and can better discriminate future same-territory ischaemic cerebrovascular events over a 12-month period than stenosis>70% and hypoperfusion on CTP.
- 1 July 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (5) , 1395-1400
Treatment of contrast induced encephalopathy: multicenter cohort study and proposed treatment algorithm
Background: Contrast induced encephalopathy (CIE) is an increasingly recognized but uncommon complication of endovascular procedures. Despite increased reports, there is limited evidence to guide clinical management. We sought to identify commonly used treatments for CIE and propose management strategies to aid clinical decision making. Methods: A retrospective multicenter study was conducted across 10 neurovascular centers in Australia. Cases were included based on previously proposed diagnostic criteria for CIE. Clinical features, treatments, and outcomes were extracted and analyzed. Descriptive statistics were used to characterize management strategies, and associations with clinical outcomes were assessed using Fisher's exact and χ 2 tests. Results: 56 patients were identified (median age 65 years; 80.4% women). Common interventions included corticosteroids (66.1%), intravenous fluids (66.1%), and antiseizure medications (prophylactic 51.8% and therapeutic 12.5%). Half required intensive care admission for neurological monitoring. Complete recovery was achieved in 87.5% of cases. Corticosteroid administration was significantly associated with symptom resolution within 72 hours (OR 4.51, 95% CI 1.19 to 17.85, P=0.022), while intravenous fluids showed a non-significant trend toward shorter symptom duration (OR 2.25, 95% CI 0.64 to 8.15, P=0.170). Conclusions: CIE generally carries a favorable prognosis. Corticosteroids appeared to shorten symptom duration and may be considered in management. Based on our findings and the existing literature, we propose a treatment algorithm to guide clinicians. Prospective validation is warranted.
- 1 July 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (5) , 1395-1400
Treatment of contrast induced encephalopathy: multicenter cohort study and proposed treatment algorithm
Background: Contrast induced encephalopathy (CIE) is an increasingly recognized but uncommon complication of endovascular procedures. Despite increased reports, there is limited evidence to guide clinical management. We sought to identify commonly used treatments for CIE and propose management strategies to aid clinical decision making. Methods: A retrospective multicenter study was conducted across 10 neurovascular centers in Australia. Cases were included based on previously proposed diagnostic criteria for CIE. Clinical features, treatments, and outcomes were extracted and analyzed. Descriptive statistics were used to characterize management strategies, and associations with clinical outcomes were assessed using Fisher's exact and χ 2 tests. Results: 56 patients were identified (median age 65 years; 80.4% women). Common interventions included corticosteroids (66.1%), intravenous fluids (66.1%), and antiseizure medications (prophylactic 51.8% and therapeutic 12.5%). Half required intensive care admission for neurological monitoring. Complete recovery was achieved in 87.5% of cases. Corticosteroid administration was significantly associated with symptom resolution within 72 hours (OR 4.51, 95% CI 1.19 to 17.85, P=0.022), while intravenous fluids showed a non-significant trend toward shorter symptom duration (OR 2.25, 95% CI 0.64 to 8.15, P=0.170). Conclusions: CIE generally carries a favorable prognosis. Corticosteroids appeared to shorten symptom duration and may be considered in management. Based on our findings and the existing literature, we propose a treatment algorithm to guide clinicians. Prospective validation is warranted.
- 12 June 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 1157-1163
Nationwide multicenter experience of contrast-induced encephalopathy following neurointervention: clinical course and outcomes
Background: Contrast-induced encephalopathy (CIE) is an increasingly observed complication following neurointervention, but remains poorly defined with limited evidence for clinical decision-making. We sought to characterize the stereotypical clinical features of CIE in a nationwide, multicenter cohort. Methods: A multicenter cohort study was conducted between 10 neurovascular sites across Australia. Patients were screened according to the previously proposed Australian diagnostic criteria. Descriptive analysis was conducted to characterize the clinical course and outcomes of CIE, and associations between clinical and radiological variables on patient outcomes were analyzed using Fisher’s exact and χ 2 tests. Results: A total of 56 patients (median age 65 years) were included. The median contrast volume was 170 mL (IQR 140–229). Median time to symptom onset was 6 hours (IQR 1–12), with frequent symptoms including motor deficit (55.4%), dysphasia (39.3%), and confusion (35.7%). Common radiological findings included sulcal effacement (45.5%) and subarachnoid contrast staining (30.9%) on CT. Hemianopia (p=0.001) and cortical blindness (p=0.018) were associated with posterior circulation interventions, while motor deficit was correlated with anterior circulation interventions (p=0.001). At discharge, 87.5% of patients achieved complete resolution of symptoms, of which 69.4% achieved complete recovery within 72 hours. Conclusion: CIE is a recognized complication of neurointervention. Symptoms occur within hours of contrast administration and correlate with the territory of contrast administration. Most patients achieve complete symptom resolution. Ongoing investigation is required to further define CIE as a clinical entity.
- 12 June 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 1157-1163
Nationwide multicenter experience of contrast-induced encephalopathy following neurointervention: clinical course and outcomes
Background: Contrast-induced encephalopathy (CIE) is an increasingly observed complication following neurointervention, but remains poorly defined with limited evidence for clinical decision-making. We sought to characterize the stereotypical clinical features of CIE in a nationwide, multicenter cohort. Methods: A multicenter cohort study was conducted between 10 neurovascular sites across Australia. Patients were screened according to the previously proposed Australian diagnostic criteria. Descriptive analysis was conducted to characterize the clinical course and outcomes of CIE, and associations between clinical and radiological variables on patient outcomes were analyzed using Fisher’s exact and χ 2 tests. Results: A total of 56 patients (median age 65 years) were included. The median contrast volume was 170 mL (IQR 140–229). Median time to symptom onset was 6 hours (IQR 1–12), with frequent symptoms including motor deficit (55.4%), dysphasia (39.3%), and confusion (35.7%). Common radiological findings included sulcal effacement (45.5%) and subarachnoid contrast staining (30.9%) on CT. Hemianopia (p=0.001) and cortical blindness (p=0.018) were associated with posterior circulation interventions, while motor deficit was correlated with anterior circulation interventions (p=0.001). At discharge, 87.5% of patients achieved complete resolution of symptoms, of which 69.4% achieved complete recovery within 72 hours. Conclusion: CIE is a recognized complication of neurointervention. Symptoms occur within hours of contrast administration and correlate with the territory of contrast administration. Most patients achieve complete symptom resolution. Ongoing investigation is required to further define CIE as a clinical entity.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 5 (1)
Symptomatic Intracranial Atherosclerosis in an Australian Context: Common and Underdiagnosed in Multiple Ethnic Groups
Background: Intracranial atherosclerosis (ICAD) is a common cause of stroke globally. We calculated the proportion of patients with stroke with symptomatic intracranial atherosclerosis in an Australian multiethnic setting, as well as diagnostic rates by stroke physicians and radiologists. Methods: This was a multicenter retrospective cohort study based in Melbourne, Australia. Demographic data (including self‐reported ethnicity) and data on vascular risk factors were collected. Symptomatic ICAD was independently identified by 2 blinded stroke neurologists using multiplanar reformats and maximum intensity projections of routinely acquired thin slice computed tomography angiography data, with disagreements resolved by a third blinded stroke neurologist. This diagnostic reference standard was compared to the proportion of patients with ICAD identified in the radiology report and stroke team clinical notes. Results: Of 1328 patients included (mean age, 73 years; 43% female), the proportion of patients with centrally read symptomatic ICAD was 14%, of whom 39% were diagnosed by the stroke clinical team and 65% by the reporting radiologist. Patients of Asian ethnicity more commonly had symptomatic ICAD than patients of European ethnicity (21% versus 14%; odds ratio, 1.5 [95% CI, 1.0–2.23]). Conclusion: Intracranial atherosclerosis is common and underdiagnosed in an Australian tertiary stroke care unit setting in patients from multiple ethnic backgrounds.
- 1 January 2025
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 5 (1)
Open AccessSymptomatic Intracranial Atherosclerosis in an Australian Context: Common and Underdiagnosed in Multiple Ethnic Groups
Background: Intracranial atherosclerosis (ICAD) is a common cause of stroke globally. We calculated the proportion of patients with stroke with symptomatic intracranial atherosclerosis in an Australian multiethnic setting, as well as diagnostic rates by stroke physicians and radiologists. Methods: This was a multicenter retrospective cohort study based in Melbourne, Australia. Demographic data (including self‐reported ethnicity) and data on vascular risk factors were collected. Symptomatic ICAD was independently identified by 2 blinded stroke neurologists using multiplanar reformats and maximum intensity projections of routinely acquired thin slice computed tomography angiography data, with disagreements resolved by a third blinded stroke neurologist. This diagnostic reference standard was compared to the proportion of patients with ICAD identified in the radiology report and stroke team clinical notes. Results: Of 1328 patients included (mean age, 73 years; 43% female), the proportion of patients with centrally read symptomatic ICAD was 14%, of whom 39% were diagnosed by the stroke clinical team and 65% by the reporting radiologist. Patients of Asian ethnicity more commonly had symptomatic ICAD than patients of European ethnicity (21% versus 14%; odds ratio, 1.5 [95% CI, 1.0–2.23]). Conclusion: Intracranial atherosclerosis is common and underdiagnosed in an Australian tertiary stroke care unit setting in patients from multiple ethnic backgrounds.